Search Results - "Esteban‐De Antonio, Ester"
-
1
Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
Published in Scientific reports (18-11-2020)“…To date, very few studies have been focused on the impact of the convergence of neuropsychiatric symptoms (NPS) and APOE ε4 on the conversion to dementia in…”
Get full text
Journal Article -
2
Author Correction: Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
Published in Scientific reports (22-02-2021)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
3
Establishing In-House Cutoffs of CSF Alzheimer’s Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort
Published in International journal of molecular sciences (01-07-2022)“…Background: Clinical diagnosis of Alzheimer’s disease (AD) increasingly incorporates CSF biomarkers. However, due to the intrinsic variability of the…”
Get full text
Journal Article -
4
Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort
Published in Alzheimer's research & therapy (20-02-2024)“…Optical coherence tomography angiography (OCT-A) is a novel tool that allows the detection of retinal vascular changes. We investigated the association of…”
Get full text
Journal Article -
5
Extracellular vesicles, the emerging mirrors of brain physiopathology
Published in International journal of biological sciences (2023)“…Extracellular vesicles are secreted by a wide variety of cells, and their primary functions include intercellular communication, immune responses, human…”
Get full text
Journal Article -
6
Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis
Published in Scientific reports (19-03-2021)“…Neuropsychiatric symptoms (NPS) have been recently addressed as risk factors of conversion to Alzheimer’s disease (AD) and other dementia types in patients…”
Get full text
Journal Article -
7
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
Published in Scientific reports (03-04-2023)“…Although beta-amyloid (Aβ) and phosphorylated tau remain the preferred targets for disease-modifying treatments (DMT) against Alzheimer’s disease (AD), part of…”
Get full text
Journal Article -
8
Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment
Published in Journal of nanobiotechnology (14-02-2023)“…In the clinical course of Alzheimer's disease (AD) development, the dementia phase is commonly preceded by a prodromal AD phase, which is mainly characterized…”
Get full text
Journal Article -
9
Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment
Published in Frontiers in aging neuroscience (08-12-2021)“…Mild cognitive impairment is often associated with affective and other neuropsychiatric symptoms (NPS). This co-occurrence might have a relevant impact on…”
Get full text
Journal Article -
10
Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort
Published in Alzheimer's research & therapy (18-03-2022)“…FACEmemory® is the first computerized, self-administered verbal episodic memory test with voice recognition. It can be conducted under minimal supervision and…”
Get full text
Journal Article -
11
Deterioro cognitivo en el paciente muy anciano: estudio retrospectivo en una consulta de neurología
Published in Revista de neurologiá (01-11-2018)Get full text
Journal Article -
12
Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type
Published in Brain (London, England : 1878) (29-07-2022)“…Alzheimer's disease has a long asymptomatic phase that offers a substantial time window for intervention. Utilizing this window of opportunity will require…”
Get full text
Journal Article -
13
Proteomic analysis reveal early differences in plasma exosomes of Aβ(+) vs Aβ(‐) patients with early‐onset mild cognitive impairment: from BIOFACE to BIOPEXAL study
Published in Alzheimer's & dementia (01-12-2023)“…Background in the clinical course of Alzheimer’s disease (AD) development, the dementia phase is commonly preceded by a prodromal AD phase, which is mainly…”
Get full text
Journal Article -
14
Macular vessel density in the superficial plexus is not associated to cerebrovascular damage in non‐demented individuals: data from the NORFACE cohort
Published in Alzheimer's & dementia (01-12-2023)“…Background Optical Coherence Tomography angiography (OCT‐A) is a novel tool that allows the detection of retinal vascular changes. The comparison of OCT‐A…”
Get full text
Journal Article -
15
Cerebral amyloid angiopathy-related transient focal neurological episodes: A transient ischemic attack mimic with an increased risk of intracranial hemorrhage
Published in Journal of the neurological sciences (15-11-2019)“…AbstractBackgroundTransient focal neurological episodes (TFNEs) are a recently recognized clinical presentation of cerebral amyloid angiopathy (CAA). Our aim…”
Get full text
Journal Article -
16
Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort
Published in Scientific reports (08-10-2022)“…Optical coherence tomography angiography (OCT-A) allows the detection of retinal vessel density (VD) loss, which is a reflection of brain vascular pathology…”
Get full text
Journal Article -
17
The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment
Published in International journal of molecular sciences (10-01-2023)“…Few studies have addressed the impact of the association between Alzheimer's disease (AD) biomarkers and NPSs in the conversion to dementia in patients with…”
Get full text
Journal Article -
18
Comparison of automated CLEIA and manual ELISA immunoassays for CSF AD biomarkers: The Fundació ACE Biomarker Research Program (FACEBREP)
Published in Alzheimer's & dementia (01-12-2021)“…Background Clinical diagnosis of Alzheimer’s disease (AD) increasingly incorporate CSF biomarkers. However due to the intrinsic variability of the…”
Get full text
Journal Article -
19
BIOFACE: A prospective study of risk factors, cognition and biomarkers in a cohort of individuals with early‐onset mild cognitive impairment at Fundació ACE
Published in Alzheimer's & dementia (01-12-2021)“…Background The diagnosis of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) is based on either cerebrospinal fluid (CSF) or neuroimaging…”
Get full text
Journal Article -
20
BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols
Published in Journal of Alzheimer's disease (01-01-2021)“…Mild cognitive impairment (MCI) due to Alzheimer's disease (AD) diagnosis is based on cerebrospinal fluid (CSF) or neuroimaging biomarkers. Currently,…”
Get more information
Journal Article